Delivery Order SPE2DR25D1205-SPE2DR26F0YD6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of OFEV (nintedanib) 100 mg capsules in a 60-count package, with a contract ceiling value of $8,630.28 and a firm fixed-price structure. This is an unset-aside competitive award that serves as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a $8,590.58 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of OFEV 150 mg capsules (60-unit quantity). The contract, which is non-set-aside and competitively awarded, represents a firm fixed-price delivery order with an ultimate completion date of August 4, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,094.99 for OFEV 100 mg capsules (60-count units) on December 10, 2025, with an ultimate completion date of January 2, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded through an open procurement process. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency (DLA) awarded a $9,094.99 delivery order to AmerisourceBergen Drug Corp for OFEV (nintedanib) 100 mg capsules (quantity 60) with a completion date of January 6, 2026. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 and extending through December 2026. The pharmaceutical supply will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,590.58 for OFEV 150 mg capsule 60-count units on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units. This competitive award, valued at $9,053.16 with a firm fixed price structure, is scheduled for completion by December 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of OFEV (pirfenidone) 100 mg capsules in quantities of 60 units, with a contract ceiling value of $9,094.99 and an ultimate completion date of January 20, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,094.99 on December 1, 2025, for the supply of Ofev (nintedanib) 100 mg capsules in quantities of 60 units. This firm fixed-price delivery order, with an ultimate completion date of December 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of OFEV (nintedanib) 100 mg capsules in quantities of 60 units, with a contract ceiling value of $8,630.28. This is a firm fixed-price delivery order with no set-aside designation, issued under open competition. The ultimate completion date is September 9, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. OFEV...
- The Defense Logistics Agency awarded a $9,053.16 delivery order to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count) with a firm fixed price arrangement. This contract, issued on December 22, 2025, with an ultimate completion date of January 14, 2026, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made on a competitive basis without any set-aside designation, and performance will occur at...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0YD6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of OFEV (Nintedanib) 100 mg capsules in a quantity of 60 units, with a ceiling value of $9,094.99 and a firm fixed price structure. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation and reflects competitively awarded procurement through open competition. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 5, 2026. OFEV is a specialty pharmaceutical used in the treatment of idiopathic pulmonary fibrosis, representing the type of specialized medical commodity that AmerisourceBergen supplies through its DLA contract vehicle to support military and federal healthcare systems globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order exemplifies the company's role in fulfilling federal medical supply needs for Defense Health Agency customers and other government healthcare programs through the flexible and comprehensive DLA pharmaceutical support mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 12/10/25 |